PJSIMP
GSK icon

P.J. Schmidt Investment Management (PJS)’s GSK GSK Stock Holding History

P.J. Schmidt Investment Management (PJS)’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-8,240
Closed -$444K – 124
2016
Q3 		$444K Hold
8,240
– – 0.17% 101
2016
Q2 		$446K Sell
8,240
-6,800
-45% -$358K 0.17% 101
2016
Q1 		$762K Sell
15,040
-1,840
-11% -$91.6K 0.3% 83
2015
Q4 		$851K Sell
16,880
-2,976
-15% -$152K 0.34% 82
2015
Q3 		$954K Sell
19,856
-1,688
-8% -$87.9K 0.42% 73
2015
Q2 		$1.12M Sell
21,544
-11,080
-34% -$624K 0.44% 66
2015
Q1 		$1.88M Sell
32,624
-9,424
-22% -$540K 0.74% 42
2014
Q4 		$2.25M Sell
42,048
-14,420
-26% -$807K 0.89% 38
2014
Q3 		$3.25M Sell
56,468
-9,868
-15% -$605K 1.33% 25
2014
Q2 		$4.43M Sell
66,336
-976
-1% -$66.1K 1.73% 20
2014
Q1 		$4.5M Buy
67,312
+348
+0.5% +$23.5K 1.78% 18
2013
Q4 		$4.47M Buy
66,964
+852
+1% +$55.2K 1.89% 18
2013
Q3 		$4.15M Sell
66,112
-1,280
-2% -$82.4K 1.9% 20
2013
Q2 		$4.21M Buy
+67,392
New +$4.28M 2.02% 18

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

P.J. Schmidt Investment Management (PJS)'s GSK Position: Q4 2016 in Review

P.J. Schmidt Investment Management (PJS) sold out of GSK (GSK) in Q4 2016, closing a stake of 8,240 shares — an estimated $444K sold.

P.J. Schmidt Investment Management (PJS) first reported a position in GSK in Q2 2013 and held it in 14 quarters. The position peaked at $4.5M in Q1 2014. 762 funds tracked by Wall St. Rank hold GSK as of Q4 2016.

  • P.J. Schmidt Investment Management (PJS) reported no remaining GSK position as of Q4 2016 after selling out during the quarter.
  • P.J. Schmidt Investment Management (PJS) sold 8,240 GSK shares in Q4 2016, an estimated $444K.
  • P.J. Schmidt Investment Management (PJS) first reported a position in GSK in Q2 2013 and held it in 14 quarters.
  • P.J. Schmidt Investment Management (PJS)'s GSK position peaked at $4.5M in Q1 2014.
  • 762 funds tracked by Wall St. Rank held GSK as of Q4 2016.

Based on P.J. Schmidt Investment Management (PJS)'s 13F filing for Q4 2016, filed 24 Jan 2017.